Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 197 participants.

Also called NCT02186561

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 197 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02186561
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02186561. Allocation not applicable; no masking; primary purpose treatment. Start 2014-07-24 (actual); primary completion 2016-11-18 (actual). Results posted on 2019-05-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
Acronym
PREMIER
Condition
Intracranial Aneurysm
Intervention (Device)
Pipeline™ Embolization Device/ Pipeline™Flex Embolization Device
Lead sponsor
Medtronic Neurovascular Clinical Affairs (class: industry)

Record details

Record id
cardio:ct-nct02186561
Content hash
96e7a25462a86eff06525de7c79f3aafb5cd6f7cd8bb499834886d104ae362be